Immune Checkpoint Blockade in Melanoma – Earlier is Better?
Administering checkpoint inhibition before surgery, known as neoadjuvant therapy, shows promise in treating bulky yet resectable melanomas, and researchers are investigating its potential in various other cancer types. This approach boasts a considerable success in high pathologic response rate, a...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2024-09-01
|
Series: | Acta Medica Lituanica |
Subjects: | |
Online Access: | https://www.journals.vu.lt/AML/article/view/32871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|